Log in

Relevant bibliographies by topics / First trimester of pregnancy

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'First trimester of pregnancy'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'First trimester of pregnancy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "First trimester of pregnancy"

1

Murugaboopathi, Sindhuja, and Hephzibah Kirubamani. "Awareness of Complications of First Trimester Pregnancy." Indian Journal of Obstetrics and Gynecology 7, no. 4 (P-2) (2019): 627–31. http://dx.doi.org/10.21088/ijog.2321.1636.7419.9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

COOPER, JOHN K. "First Trimester Pregnancy Complications." Clinical Obstetrics and Gynecology 50, no. 1 (March 2007): 1. http://dx.doi.org/10.1097/grf.0b013e318032ff14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Hanafy, Samy, Neveen E. Srour, and Taymour Mostafa. "Female sexual dysfunction across the three pregnancy trimesters: an Egyptian study." Sexual Health 11, no. 3 (2014): 240. http://dx.doi.org/10.1071/sh13153.

Full text

Abstract:

Background Pregnancy is a special period in the life of women characterised by physical, hormonal and psychological changes that, in conjugation with social and cultural influences, could affect women’s sexuality as well as couples’ sexual relationships. This cross-sectional study aimed to evaluate female sexual dysfunction (FSD) among the three pregnancy trimesters. Methods: A total of 300 healthy heterosexual pregnant Egyptian women with stable marital relationships were included. The Female Sexual Function Index (FSFI) questionnaire was used as a standard method for measuring female sexual function in each pregnancy trimester. Results: There was no significant relationship between FSD and women’s education, work, gravidity and parity. The incidence of FSD demonstrated significant alterations throughout pregnancy, being 68% in the first trimester, decreasing in the second trimester to 51% and increasing to 72% in the third trimester. Sexual desire decreased in the first trimester, was variable in the second trimester and decreased at the end of the third trimester (3.5 ± 1.2, 3.7 ± 1.2 and 3.4 ± 1.1 respectively). Sexual satisfaction declined significantly in the first trimester compared with the second and the third trimesters (4.2 ± 1.1, 4.8 ± 0.8 and 4.6 ± 1.0 respectively). Scores for the arousal, lubrication and orgasm domains were significantly decreased in the third trimester, where pain was increased in the second trimester compared with the first and third trimesters. Conclusion: Female sexual function is affected during pregnancy, with a significant change in all Female Sexual Function Index domains, especially in the first and third trimesters.

APA, Harvard, Vancouver, ISO, and other styles

4

Ukwenya, Victor, Afodun Adams, KK Quadri, and Ashaolu James. "First trimester tubal ectopic pregnancy." West African Journal of Radiology 22, no. 1 (2015): 36. http://dx.doi.org/10.4103/1115-1474.146148.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Lui, Man-Wa, and Pak-Chung Ho. "First trimester termination of pregnancy." Best Practice & Research Clinical Obstetrics & Gynaecology 63 (February 2020): 13–23. http://dx.doi.org/10.1016/j.bpobgyn.2019.06.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Patil, Dr Mithil. "Level of Papp-A in The First Trimester of Pregnancy & The Pregnancy Outcome." International Journal of Scientific Research 2, no. 2 (June 1, 2012): 322–24. http://dx.doi.org/10.15373/22778179/feb2013/108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Míguez, M. Carmen, and M. Belén Vázquez. "Prevalence of Depression during Pregnancy in Spanish Women: Trajectory and Risk Factors in Each Trimester." International Journal of Environmental Research and Public Health 18, no. 13 (June 24, 2021): 6789. http://dx.doi.org/10.3390/ijerph18136789.

Full text

Abstract:

The aims of this research were to determine the trajectories of probable depression and major depression during pregnancy and to identify the associated and predictor variables (sociodemographic, pregnancy-related, and psychological) for both conditions in each trimester of pregnancy. A longitudinal study was carried out with 569 pregnant Spanish women who were assessed in the first, second, and third trimesters of pregnancy. Depression was assessed using the Edinburgh Postnatal Depression Scale and a clinical interview. Measures of anxiety and stress were also included. The prevalence of probable depression in the first, second, and third trimesters was 23.4%, 17.0%, and 21.4%, respectively, and that of major depression was 5.1%, 4.0%, and 4.7%. Thus, the prevalence of both conditions was the highest in the first and third trimesters. The trajectories of probable depression and major depression followed the same pattern throughout pregnancy. All of the psychological variables studied were associated with both conditions in all three trimesters, with perceived stress being a predictor at all times. The association between the other variables and both conditions of depression was similar. Two exceptions stand out: having had previous miscarriages, which was only associated with probable depression and was also a predictor, in the first trimester; and complications during pregnancy, which was only associated with probable and major depression in the third trimester. These findings should be taken into account in routine pregnancy follow-ups, and necessary interventions should be started in the first trimester.

APA, Harvard, Vancouver, ISO, and other styles

8

Kamble, Pradnya Digambar, Amarjeetkaur Bava, Mansi Shukla, and Y. S. Nandanvar. "First trimester bleeding and pregnancy outcome." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 6, no. 4 (March 30, 2017): 1484. http://dx.doi.org/10.18203/2320-1770.ijrcog20171414.

Full text

Abstract:

Background: The outcome of first trimester vaginal bleeding is a matter of debate. This study sought to determine the maternal and perinatal outcome in patients presenting with first trimester vaginal bleeding.Methods: This prospective observational study was done on 1007 women with first trimester vaginal bleeding at a tertiary care hospital in Mumbai over a period of one year. A detailed history was taken and USG was done to confirm diagnosis. All these patients were evaluated for the outcomes including threatened abortions, spontaneous, complete or incomplete abortions, sub-chorionic hematoma, Intra-uterine Fetal Demise, missed abortions, second and third trimester bleeding, Intra-uterine Growth Restriction, premature rupture of membranes and preterm deliveries.Results: Out of the 11835 confinements 1007 patients presented with first trimester vaginal bleeding. The incidence was highest (52.3%) in the age group of 21-30 years. 63.9% primigravidas presented with first trimester bleeding as compared to 36.1% of multigravidas. It was seen that 76.9% patients who presented before 6 weeks aborted whereas only 7% patients who presented after 10 weeks aborted. Out of the 163 patients that continued pregnancy after first trimester vaginal bleeding 1.8% had a second trimester abortion, 15.3% went into preterm labour 6.75% has premature rupture of membranes and 1.8% had antepartum hemorrhage.Conclusions: According to the results of present study, first trimester vaginal bleeding predicts auxiliary maternal and fetal complications. Also, as the clinical intermediation has an important role in continuance of pregnancy and in reducing the fetal complications precise management and planning by physician is important.

APA, Harvard, Vancouver, ISO, and other styles

9

Ginsberg, J. S., P. Brill-Edwards, R. F. Burrows, R. Bona, P. Prandoni, H. R. Büller, and A. Lensing. "Venous Thrombosis during Pregnancy: Leg and Trimester of Presentation." Thrombosis and Haemostasis 67, no. 05 (1992): 519–20. http://dx.doi.org/10.1055/s-0038-1648485.

Full text

Abstract:

SummaryIn order to determine the relative frequencies of left and right leg venous thrombosis during pregnancy and the frequencies of venous thrombosis during the three trimesters, a cohort study of 60 consecutive patients with a first episode of venous thrombosis during pregnancy was performed. Fifty-eight women had isolated left leg thrombosis, two patients had bilateral venous thrombosis and no patient had isolated right leg venous thrombosis. Thirteen patients had venous thrombosis during the first trimester (21.7%), 28 during the second trimester (46.7%) and 19 during the third trimester (31.7%). These findings indicate that patients with symptoms in the right leg rarely have venous thrombosis. Because leg pain and swelling occur most frequently during the third trimester but venous thrombosis is relatively equally distributed during all three trimesters, patients presenting earlier during pregnancy are more likely to have venous thrombosis than patients presenting later during pregnancy.

APA, Harvard, Vancouver, ISO, and other styles

10

Fuchs, Anna, Iwona Czech, Jerzy Sikora, Piotr Fuchs, Miłosz Lorek, Violetta Skrzypulec-Plinta, and Agnieszka Drosdzol-Cop. "Sexual Functioning in Pregnant Women." International Journal of Environmental Research and Public Health 16, no. 21 (October 30, 2019): 4216. http://dx.doi.org/10.3390/ijerph16214216.

Full text

Abstract:

Sexual activity during pregnancy is determined by emotional, psychosocial, hormonal, and anatomical factors and varies during trimesters. This work aimed to establish women’s sexual activity during each trimester of pregnancy. A total of 624 women were included in the study and filled in the questionnaire three times, once during each trimester of pregnancy. The first part of the survey included questions about socio-demographic characteristics, obstetric history, and medical details of a given pregnancy. The second part was the Polish version of the female sexual function index (FSFI) questionnaire. Comparison of the mean scores for the overall sexual function of each trimester revealed clinically relevant sexual dysfunction in the second and third trimesters (mean values 25.9 ± 8.7 and 22.7 ± 8.7, respectively; p < 0.01). Women were most sexually active during their second trimester. In the first trimester of pregnancy, women were most likely to choose intercourse in the missionary position. Women with vocational education were characterized by the lowest and homogenous FSFI values. Total FSFI score depended on the martial status—the highest value pertained to married women (25.2 ± 6.9; p = 0.02).

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "First trimester of pregnancy"

1

Wieringa-de, Waard Margrethe. "Bleeding in the first trimester of pregnancy." [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2002. http://dare.uva.nl/document/61606.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Niemimaa, M. (Marko). "First trimester screening for Down syndrome." Doctoral thesis, University of Oulu, 2003. http://urn.fi/urn:isbn:9514270290.

Full text

Abstract:

Abstract The aim of the present study was to evaluate the efficacy of the first trimester screening for Down syndrome (DS) in an unselected low-risk Finnish population. The study involved 4,617 women who attended screening between the 8th and 14th weeks of pregnancy in 1998-2000. They gave a blood sample for the measurement of pregnancy associated plasma protein A (PAPP-A) and free beta human chorionic gonadotrophin (β-hCG). Of these women, 3,178 also had an ultrasound examination for the measurement of fetal nuchal translucency (NT). The risk figure for every screened woman was calculated using a computerized risk figure program. The risk 1 in 250 was used as a cut-off. The subgroup of screen positives comprised 5.8% of the study group. There were 16 DS cases. The combined method (maternal age, NT and the biochemical markers) detected 77% of the affected pregnancies. NT combined with maternal age gave a detection rate of 69%. Serum markers without NT combined with maternal age found 75% of the Down's. In 49 consecutive singleton in-vitro-fertilization pregnancies, the β-hCG value was more often elevated compared to spontaneous pregnancies, increasing the false positive rate. In 67 twin pregnancies, the serum marker levels were approximately double those in singletons. Smoking reduced PAPP-A by 20% making the smokers more likely to get a positive screening result. To determine the impact of the screening on the live born incidence of DS, two historical populations were compared. The first group was screened by second trimester serum samples (β-hCG and AFP) and the second group by first trimester ultrasound examination. When detection rates were at the same level, the second trimester screening reduced the number of live born Down's children more effectively. In conclusion, the first trimester combined method (maternal age, NT, β-hCG and PAPP-A) for Down syndrome screening is efficient in an unselected low risk population. The biochemical screening is not recommended in IVF-pregnancies.

APA, Harvard, Vancouver, ISO, and other styles

3

Marttala, J. (Jaana). "First trimester screening and Down syndrome." Doctoral thesis, Oulun yliopisto, 2011. http://urn.fi/urn:isbn:9789514294815.

Full text

Abstract:

Abstract The purpose of this study was to evaluate extended first trimester screening for severe chromosomal disorders and adverse pregnancy outcomes in singleton pregnancies among the general population in Finland. Maternal serum biochemical markers, pregnancy associated plasma protein-A (PAPP-A) and free beta human chorionic gonadotropin (fβ-hCG), and fetal nuchal translucency (NT) thickness were measured during the gestational weeks 8+0–13+6. A computerized risk figure program was used to calculate an individual risk figure for chromosomal disorders. It was investigated whether the screening parameter, PAPP-A, is associated with adverse pregnancy outcomes. The prevalence of Down syndrome (DS) cases in Finland during the years 2002–2006 was 1:364 (N=795). The proportion of women aged 35 years or older increased from 5–10% in the years 1980–1990 to 19.1% during the study period. Most DS cases (61.1%) presented in that age group. The first trimester combined screening for Down syndrome yielded a detection rate (DR) of 81.9% for a 4.3% false positive rate (FPR). The performance was evaluated among 76949 voluntary women during the study period of 01.05.2002–31.12.2008. There were 188 cases of DS. The screening worked better among the older women. The number of invasive procedures needed to detect one case of DS was higher among the younger women. Adding specific algorithms for screening of other chromosomal abnormalities yielded DR of 74.0% for trisomy 18 (T18) and 54.5% for trisomy 13 (T13) with an additional increase of 0.3% FPR. For chromosomal abnormalities other than T18 and T13, the specific algorithms did not improve the screening performance. Low first trimester maternal serum levels of PAPP-A (≤0.30 MoM) were significantly associated with small for gestational age (SGA) newborns and stillbirths (SBs). The combined screening method for DS works well in practice and has been standardized in Finland. In screening for trisomies 18 and 13 a specific algorithm is reasonable. Low first trimester levels of PAPP-A could be used as an independent marker for pregnancies at high risk for SGA babies and SBs
Tiivistelmä Tutkimuksen tarkoituksena oli arvioida laajennetun ensimmäisen raskauskolmanneksen kromosomipoikkeavuuksien seulonnan toimivuutta yksisikiöisissä raskauksissa suomalaisessa normaaliväestössä. Äidin seerumin biokemialliset merkkiaineet, raskauteen liittyvä valkuaisaine A (PAPP-A) ja raskaushormoni (fβ-hCG) sekä sikiön niskaturvotus mitattiin raskausviikoilla 8+0–13+6. Yksilöllinen riskiluku kromosomipoikkeavuuksille laskettiin käyttäen tietokoneen riskinlaskentaohjelmaa. Seulonnan merkkiaineen, PAPP-A:n, matalien pitoisuuksien yhteyttä epäsuotuisiin raskauden lopputuloksiin tutkittiin. Downin oireyhtymän esiintyvyys Suomessa oli 1:364 (N=795) vuosina 2002–2006. 35-vuotiaiden tai sitä vanhempien naisten osuus oli tutkimusaikana 19.1 %, mikä on huomattavasti suurempi kuin vuosien 1980–1990: 5–10 %. Näiden naisten sikiöiden joukosta löytyi suurin osa Down oireyhtymistä (61.1 %). Ensimmäisen raskauskolmanneksen yhdistelmäseulonnan toimivuutta tutkittiin aikana 01.05.2002–31.12.2008. Tutkimukseen osallistui 76 949 vapaaehtoista naista. Joukossa oli 188 Downin oireyhtymätapausta. Seulonnan herkkyys Downin oireyhtymälle oli 81.9 % ja tarkkuus 4.3 %. Seulonta toimi parhaiten vanhempien naisten joukossa. Niiden kajoavien toimenpiteiden määrä, jotka tarvittiin yhden Down-sikiön löytämiseksi, oli suurempi nuorten naisten joukossa. Tutkimuksessa Downin oireyhtymän algoritmiin lisättiin spesifiset algoritmit trisomioille 18 ja 13, jolloin saavutettiin 74.0 %:n herkkyys trisomialle 18 ja 54.5 %:n herkkyys trisomialle 13. Väärien positiivisten seulontatulosten määrä kasvoi 0.3 %:n verran. Seulonnan toimivuus muiden kromosomipoikkeavuuksien joukossa ei parantunut spesifisten algoritmien avulla. Lisäksi matalan PAPP-A-pitoisuuden yhteys pienipainoisuuten ja kuolleena syntyneisyyteen oli tilastollisesti merkittävä. Tutkimus osoitti, että esimmäisen raskauskolmanneksen yhdistelmäseulonta toimii hyvin käytännössä. Trisomioiden 18 ja 13 seulonnassa spesifisten algoritmien käyttö on järkevää. Matalaa ensimmäisen raskauskolmanneksen PAPP-A-arvoa voitaisiin käyttää itsenäisenä riskimerkkiaineena raskauksille, joissa pienipainoisuuden ja kuolleena syntymisen riski on kohonnut

APA, Harvard, Vancouver, ISO, and other styles

4

Tong, Stephen. "Investigation of novel endocrine markers of early pregnancy and later pregnancy health." Monash University, Dept. of Obstetrics and Gynaecology, 2004. http://arrow.monash.edu.au/hdl/1959.1/9689.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Bottomley, Cecilia. "Prediction of first trimester pregnancy outcome using prior risk factors and ultrasound findings." Thesis, St George's, University of London, 2015. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.676895.

Full text

Abstract:

The aim of this thesis was to examine a large cohort of women undergoing pregnancy assessment before 12 weeks gestation, collecting demographic, symptom and ultrasound data. I aimed to examine the role of prior risk factors and initial ultrasound findings in the prediction of first trimester viability of these pregnancies. Further, I aimed to develop and validate models to counsel women in future about the likely chance of viability for any individual pregnancy. The hypotheses were: (1) There are prior risk and ultrasound factors that can predict likely pregnancy viability, (2) These factors can be used to predict pregnancy loss or ongoing viability in any particular pregnancy and (3) In predicting outcome, both mathematical models } and 'simple rules' (for everyday clinical use) can perform well. ) The prospective study included 1881 women, with median age 32 years and median gestational age at presentation of 50 days. 46% presented with bleeding and 36% with pain. The final outcome was an ongoing pregnancy in 885 (61.7%) and early pregnancy loss in 550 (38.3%) women. Both 'prior risks' (maternal age and bleeding score) and ultrasound factors (gestation and yolk sac size and fetal heart beat) predicted viability. Mathematical models developed showed that these factors used separately and when combined together predicted viability with accuracy. The final scoring system using both demographic and ultrasound variables together was proven to be highly accurate in prediction of pregnancy viability, performing with a sensitivity of 0.92, specificity of 0.73, positive predictive value of 84.7% and negative predictive value of 85.4%. All 3 study hypotheses were proven. The conclusion of this study is that using routinely collected demographic and ultrasound data an accurate individualised likelihood of ongoing viability can be offered to women in early pregnancy with and without symptoms of pain or bleeding.

APA, Harvard, Vancouver, ISO, and other styles

6

Chen, Min, and 陳敏. "Application of ultrasonography in early pregnancy." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2006. http://hub.hku.hk/bib/B36603314.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Ramos-Orosco, Elizabeth J. "Comment on first trimester maternal serum analytes and second trimester uterine artery doppler in the prediction of preeclampsia and fetal growth restriction." Taiwan Association of Obstetrics and Gynecology, 2018. http://hdl.handle.net/10757/622873.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Buckley, Rebecca J. "The role of decidual macrophages in the first trimester of pregnancy and in the pregnancy complication pre-eclampsia." Thesis, St George's, University of London, 2016. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.719150.

Full text

Abstract:

Uterine decidual macrophages are present throughout pregnancy however, little is known of their phenotype or functional relevance. This study aimed to further the understanding of decidual macrophage phenotype and function across the first and early second trimester. In addition, this study aimed to compare decidual macrophages derived from normal pregnancies and those at increased risk of developing complications (pre-eclampsia, FGR and stillbirth). Macrophage phenotype was shown to differentially affect trophoblast behaviour, with pro-inflammatory (M1 -like) macrophages inducing trophoblast apoptosis and impairing trophoblast motility, proliferation and network formation, when compared with an anti-inflammatory (M2-like) phenotype. Decidual macrophages were found to become increasingly anti-inflammatory with gestation; with upregulation of CD206 expression and downregulation of CD86, TLR4 and CD11c expression between the 4th and 14th week of pregnancy. The relative risk of a pregnancy developing complications was calculated by uterine artery resistance indices (Rl) measured by Doppler Ultrasound scanning, enabling phenotypic and functional comparisons to be made between decidual macrophages from normal and higher risk pregnancies. Decidual macrophages from normal pregnancies and those with a higher risk were found to differ in their cytokine secretion profiles, with those from higher risk pregnancies having reduced TNF-a, IL-8, VEGF, IL-1 ra and M-CSF secretion. Decidual macrophages from pregnancies with a higher risk of developing complications were also found to increase trophoblast apoptosis, reduce trophoblast proliferation, and impair trophoblast chemotaxis and network formation, when compared to decidual macrophages from normal pregnancies. Vascular smooth muscle apoptosis, proliferation and motility was not found to be affected by decidual macrophages. When decidual NK cells were cultured with secreted factors from decidual macrophages no effect on decidual NK phenotype was observed. Conversely, decidual macrophages cultured with decidual NK cell secreted factors were found to have elevated expression of CD11c and TLR4. The shift in decidual macrophage phenotype with advancing gestation likely reflects the requirement for tolerance of the semi-allogeneic fetus to support a successful pregnancy. The differential regulatory effect of decidual macrophages from normal and higher risk pregnancies on trophoblast phenotype and function are particularly interesting given that aberrant trophoblast invasion and spiral artery remodelling is related to the pathology of pre-eclampsia. These observations suggest that preeclampsia is preceded by impaired decidual macrophage-trophoblast interactions.

APA, Harvard, Vancouver, ISO, and other styles

9

Vukas, Radulovic Nina. "Clinical, biochemical and morphological aspects of cervical ripening in the first trimester /." Göteborg : Department of Obstetrics and Gynecology, Institute of Clinical Sciences, The Sahlgrenska Academy, 2009. http://hdl.handle.net/2077/20456.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Alyahyaei, Zahraa. "The role of IL-33 and ST2 in early pregnancy." Thesis, University of Oxford, 2014. http://ora.ox.ac.uk/objects/uuid:a6fd7c02-feeb-4fe5-b8e1-5713a65653b9.

Full text

Abstract:

Regulation of the growth and differentiation of trophoblast cells is critical for successful embryo implantation and placentation. Cytokines are key players in these processes, as well as modulating the maternal immune response to prevent rejection of the conceptus. This thesis focused on the investigation of the cytokine interleukin (IL) - 33 and its receptor, ST2. ST2 has two isoforms, a functional cell surface receptor (ST2L) and a soluble decoy receptor (sST2). Previous work in this laboratory had shown that the human placenta expresses both IL-33 and sST2 at term. The aim of this thesis was to investigate IL-33 and ST2 in early pregnancy, the time when trophoblast is at its most active, with a view to better understanding their role. IL-33 and ST2 mRNA and protein were examined in 14 first trimester placentas from 6-12 weeks of gestation. IL-33 was localized to cells in the villous stroma, whereas ST2 was present in the syncytiotrophoblast, villous cytotrophoblast and the invasive extravillous cytotrophoblast of the cell columns. Secretion of sST2, but not IL-33, by the placenta was found. Investigation of pre-implantation embryos showed the presence of ST2, but not IL-33 protein. Decidualized endometrium was investigated as a potential source of IL-33 and sST2 at the maternal-fetal interface and, although mRNA for both was present, no protein could be found. The key finding was that sST2, rather than ST2L, was the predominant isoform in the placenta. This led us to reconsider the hypothesis that IL-33/ST2 interactions in the placenta are important for successful pregnancy and raised the possibility that they may have independent roles. Using trophoblast cell lines as a model, it was shown that sST2 binds to trophoblast cells, significantly inhibits their proliferation and stimulates their invasion in vitro. This is the first report of this novel role for sST2 in pregnancy. Thus these studies have shown that sST2 may play an important role in implantation and placentation through controlling trophoblast invasion.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "First trimester of pregnancy"

1

International Symposium on First Trimester Fetal Diagnosis (1985 Lausanne, Switzerland). Chorionic villi sampling (CVS): International Symposium on First Trimester Fetal Diagnosis, Lausanne, November 1-2, 1985. Edited by Pescia G. ed and Nguyen The H. ed. Basel: Karger, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

1938-, Teoh Eng-Soon, Ratnam S. S, and Wong Peng-Cheang, eds. Ovulation and early pregnancy: With special supplement on adolescent sexuality. Carnforth, Lancs., U.K: Parthenon Pub. Group, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Profet, Margie. Pregnancy sickness: Using your body's natural defenses to protect your baby-to-be. Reading, Mass: Addison-Wesley, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

G, Farquharson Roy, and Stephenson Mary D, eds. Early pregnancy. Cambridge: Cambridge University Press, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Profet, Margie. Protecting your baby-to-be: Preventing birth defects in the first trimester. Reading, Mass: Addison-Wesley, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Kulin, Nathalie A. Pregnancy outcome following first trimester maternal exposure to the newer selective serotonin reuptake inhibitors. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Parker, Philip M., and James N. Parker. Early pregnancy: A medical dictionary, bibliography, and annotated research guide to internet references. San Diego, CA: ICON Health Publications, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Kao, Chien-Huei. First time Taiwanese fathers' lived experiences during the third trimester of their wives' pregnancy, labour and delivery and the initial postnatal period: a phenomenological study. [S.l: The author], 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

What to expect when you're expected: A fetus's guide to the first three trimesters. New York: Spiegel & Grau, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Garite, Thomas J. Trimester. Minden, NV: Marshall Educational Health Solutions, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "First trimester of pregnancy"

1

Hansmann, Mandfred, Bernhard-Joachim Hackelöer, and Alfons Staudach. "Pregnancy (First Trimester)." In Ultrasound Diagnosis in Obstetrics and Gynecology, 35–69. Berlin, Heidelberg: Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70423-9_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Do, Linda, and James M. Shwayder. "Ectopic Pregnancy: Pregnancy of Unknown Location (PUL)." In First-Trimester Ultrasound, 283–98. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-20203-7_16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Maulik, Dev, Timothy L. Bennett, Blake Porter, Shilpa Babbar, and Devika Maulik. "Doppler Sonography in Early Pregnancy." In First-Trimester Ultrasound, 195–212. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-20203-7_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Hack, Kalesha, and Phyllis Glanc. "Normal First Trimester of Pregnancy." In First-Trimester Ultrasound, 99–129. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-20203-7_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Porche, Lea M., Steven Warsof, and Alfred Abuhamad. "Fetal Biometry in Early Pregnancy." In First-Trimester Ultrasound, 153–65. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-20203-7_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Hernandez-Andrade, Edgar, and Manasi S. Patwardhan. "The Fetal Heart in Early Pregnancy." In First-Trimester Ultrasound, 173–94. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-20203-7_11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Canavan, Timothy P., and Joan M. Mastrobattista. "First-Trimester Ultrasound: Early Pregnancy Failure." In First-Trimester Ultrasound, 253–82. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-20203-7_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Gonçalves, Luís F. "Three-Dimensional Ultrasound: A Role in Early Pregnancy?" In First-Trimester Ultrasound, 213–21. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-20203-7_13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Samson, Chelsea R., Rochelle F. Andreotti, Rifat A. Wahab, Glynis Sacks, and Arthur C. Fleischer. "Sonography of Pelvic Masses Associated with Early Pregnancy." In First-Trimester Ultrasound, 383–95. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-20203-7_21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Timor-Tritsch, Ilan E., Ana Monteagudo, and Terri-Ann Bennett. "A Consequence of Cesarean Delivery: First-Trimester Cesarean Scar Pregnancy." In First-Trimester Ultrasound, 299–325. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-20203-7_17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "First trimester of pregnancy"

1

Fitria, Nurhidaya, and Ida Lestari Tampubolon. "The Effect of Ginger Extract Consumption on Reducing Morning Sickness in First Trimester of Pregnant Women at Pratama Mariana Clinic Medan, North Sumatra." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.03.44.

Full text

Abstract:

ABSTRACT Background: Nausea and vomiting are common in pregnant women, and the condition may be a mild or severe disabling disease. Nausea and vomiting are common in the early stages of pregnancy, affecting 70-80% of pregnant mothers. In most women, vomiting begins between 4-7 weeks of pregnancy. Nausea and vomiting are usually mild and self-limiting, but some mothers have a deeper course and cause pregnancy vomiting. This study aimed to analyze the effectiveness of ginger extract consumption on reducing morning sickness in first trimester of pregnant women at Pratama Mariana Clinic Medan, North Sumatra. Subject and Method: This was a quasi experiment study with pretest-posttest control group design conducted in Pratama Mariana Clinic, Medan from July to August 2018. A sample of 15 pregnant women. The dependent variable was emesis gravidarum. The independent variable was extract of ginger. The data were collected by observation and analyzed by wilcoxon test. Result: The extract of ginger is effective to reduce nausea and vomiting in first trimester pregnancy women after ginger extract was given (Mean= 1.93; SD= 0.26) was higher than before (Mean= 1.20; SD= 0.41), and it was statistically significant (p <0.001). Conclusion: The extract of ginger is effective to reduce nausea and vomiting in first trimester pregnancy women after ginger extract Keywords: Emesis gravidarum, extract of ginger Correspondence: Nurhidaya Fitria. Helvetia Institute of Health, Sumatera Utara. Email: nurhidayafitria@gmail.com. Mobile: 082385317328. DOI: https://doi.org/10.26911/the7thicph.03.44

APA, Harvard, Vancouver, ISO, and other styles

2

Dewi, Rahma Kusuma, and Halimatus Saidah. "Relationship between Gravidity and Severity of Emesis Gravidarum in Trimester I Pregnant Women at PMB Fatimatu Zahrok Midwifery Care, Kediri, East Java." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.03.77.

Full text

Abstract:

ABSTRACT Background: Emesis gravidarum or nausea and vomiting has commonly occurred during pregnancy. However, excessive nausea and vomiting in early pregnancy have a potentially adverse effect on pregnancy outcomes. This study aimed to investigate the relationship between gravidity and severity of emesis gravidarum in women with first-trimester of pregnancy at PMB Fatimatu Zahrok Midwifery Care, Kediri, East Java. Subjects and Method: This was a cross-sectional study conducted at PMB Fatimatu Zahrok Midwifery Care, Kediri, East Java, from July to August 2020. A sample of 32 women with first-trimester of pregnancy was selected for this study. The dependent variable was severity of emesis gravidarum categorized into mild to moderate and severe. The independent variable was the number of gravidities categorized into primigravida and multigravida. The data were collected using questionnaire. The data were analyzed by chi-square. Results: Multigravida reduced the severity of emesis gravidarum (OR= 0.14; 95% CI= 0.02 to 0.85; p= 0.034). Conclusion: Multigravida reduces the severity of emesis gravidarum in women with first-trimester pregnancy. Keywords: emesis gravidarum, first trimester, gravidity, severity, pregnant women Correspondence: Rahma Kusuma Dewi. Faculty of Health Sciences, Universitas Kadiri. Jl. Selomangleng No 1, Kediri, East Java. Email: rahmakusumadewi@unik-kediri.ac.id. Mobile: +6281229440101. DOI: https://doi.org/10.26911/the7thicph.03.77

APA, Harvard, Vancouver, ISO, and other styles

3

Bracamontes Piña, María Georgina, Erik Bojorges-Valdez, Lisbeth Camargo Marín, Mario Guzmán Huerta, Moisés Sánchez Rivera, and Verónica Medina Bañuelos. "Fetal biometric measurements during the first trimester of pregnancy." In 12th International Symposium on Medical Information Processing and Analysis, edited by Eduardo Romero, Natasha Lepore, Jorge Brieva, and Ignacio Larrabide. SPIE, 2017. http://dx.doi.org/10.1117/12.2256899.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Meschengieser, S. S., A. I. Woods, and M. Z. Lazzari. "ANTICOAGULATION IN PREGNANCY IN PATIENTS WITH CARDIAC VALVE PROSTHESIS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643266.

Full text

Abstract:

The use of oral anticoagulation in pregnancy is controversial due to the risk of embryopathy (1° trimester), intracerebral hemorrhages (2° trimester) and the use of heparin is associated with a high morbidity due to abortion and prematurity. The outcome of 50 pregnancies in 30 patients with heart prosthesis was evaluated. Acenocoumarol and aspirin 500 mg/daily were given in all the patients since their surgery. Anticoagulant doses were controlled with prothrombin time (PT) performed with human brain thromboplastin and APTT. The therapeutic range for the PT was the International Calibrated Ratio (ICR) 2.5 to 3.5. In 12 pregnancies, oral anticoagulation was replaced by subcutaneous heparin in the first trimester; the same policy was followed before delivery except in 4 cases. The foetal loss was 34% with equal distribution along the three trimesters and no correlation with excess of anticoagulation. The incidence of hemorrhage was 6% and the rate of cerebral embolism was also 6% (3 on to 50). Two of the three episodes of embolism appeared while patients were on heparin. A total of 33 normal babies were born (66%). No typical warfarin embryopathy was found and no perinatal mortality was observed. A slight reduction in the anticoagulant doses was necessary in almost half of the cases.As the rate of foetal loss with heparin is not better than with oral anticoagulants and the incidence of embolism is higher, we are doubtful about the indication of subcutaneous heparin in the first trimester considering our absence of malformations with the acenocoumarin.

APA, Harvard, Vancouver, ISO, and other styles

5

Medalla, R., and L. David-Bustamante. "178 The accuracy of ultrasound in diagnosing first trimester molar pregnancy." In IGCS 2020 Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2020. http://dx.doi.org/10.1136/ijgc-2020-igcs.155.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Diana, Sulis, Chatarina Umbul Wahyuni, and Budi Prasetyo. "Effect of Obstructive Sleep Apnea on Incidence of Pre-eclampsy in Pregnant Women: A Systematic Review." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.03.82.

Full text

Abstract:

ABSTRACT Background: The prevalence of preeclampsia is around 5-8% of all diseases that occur during pregnancy. There was an increase from 10.5% of women with OSA in the first trimester to 26.7% in the third trimester. This study aimed to investigate the effect of obstructive sleep apnea on incidence of preeclampsia in pregnant women. Subjects and Method: A systematic review was conducted by searching the articles from PubMed and Google Scholar databases published between 2015 to 2019. An obstructive sleep apnoea (OSA) analysis was performed. Sensitivity analysis was performed to identify designs, summary results and publication estimates. Results: As many as 15 studies with a total of 1,837 subjects were included. OSA during pregnancy was associated with an increased risk of preeclampsia. The selected studies were conducted in observational designs. The existing studies showed that maternal OSA was significantly associated with preeclampsia (aOR= 1.96; 95% CI= 1.30 to 2.42). Conclusion: There is the adverse relationship of OSA and preeclampsia. OSA increases the risk of multiple pregnancy and perinatal complications. Keywords: preeclampsia, OSA, pregnancy Correspondence: Sulis Diana. Doctoral Program, Faculty of Public Health, Universitas Airlangga, Surabaya, East Java. Email: Diana.sulis6@gmail.com. Mobile: +6282234209942. DOI: https://doi.org/10.26911/the7thicph.03.82

APA, Harvard, Vancouver, ISO, and other styles

7

Zefanya, Caroline, and Denrich Suryadi. "The Effect of Social Support on Pregnancy-Related Anxiety in First Trimester Expecting Mothers." In International Conference on Economics, Business, Social, and Humanities (ICEBSH 2021). Paris, France: Atlantis Press, 2021. http://dx.doi.org/10.2991/assehr.k.210805.085.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Chaudhary, Sushila. "Successful pregnancy outcome in recurrent ovarian cancer." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685320.

Full text

Abstract:

Incidences of ovarian cancer in pregnancy are increasing nowadays due to routine use of ultrasonography in first trimester and postponement of childbirth to an older age. Reported incidence of ovarian tumor in pregnancy is 1:1000 among them3.6% are malignant. We report a case of recurrent ovarian tumor with successful pregnancy outcome. She was a 26 yr old primi had ovarian cancer recurrence 2 year after primary surgery. In present pregnancy she was given chemotherapy with two doses of carboplatin, and had viable baby at 34 weeks of pregnancy. At present mother and baby are doing well and on regular follow-up at radiotherapy departments.

APA, Harvard, Vancouver, ISO, and other styles

9

Cabaset, S., JP Krieger, A. Richard, S. Rohrmann, and K. Quack Lötscher. "Vitamin D status and its determinants in healthy pregnant women living in Switzerland in the first trimester of pregnancy." In Gemeinsam forschen – gemeinsam handeln. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1606023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Declerck, P. J., M. C. Alessi, M. Verstreken, E. K. O. Kruithof, I. Juhan-Vague, and D. Collen. "MEASUREMENT OF PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI-1) IN PLASMA WITH AN ELISA BASED ON TWO MURINE MONOCLONAL ANTIBODIES." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644449.

Full text

Abstract:

An enzyme-linked immunosorbent assay (ELISA) for quantitation of plasminogen activator inhibitor 1 (PAI-1) was developed, based on two murine monoclonal antibodies (MA-7D4B7 and MA-7F5), raised against purified PAI-1 from HT-1080 fibrosarcoma cells, which react with non-overlapping epitopes. MA-7D4B7 was coated on microtiter plates and bound PAI-1 antigen was quantitated with MA-7F5 conjugated with horseradish peroxidase.In normal plasma, collected on citrate at pH 7.4, the PAI-1 level is 27 ± 16 ng/ml (mean ± SD, n=ll), with a corresponding value of 19 ± 11 ng/ml (n=12) in plasma collected on acid citrate pH 4.5, which inhibits the release of PAI-1 from platelets. The lower limit of the assay in plasma is 2 ng/ml; the intra-assay, inter-assay and inter-dilution coefficients of variation are 5.2%, 8.0% and 7.1% respectively.This ELISA was used to measure PAI-1 levels in plasma (collected on citrate, pH 7.4) of non-pregnant women and of women at different stages of pregnancy. A progressive increase is observed : before: 20±9 ng/ml, n=7; first trimester: 25 ± 12 ng/ml, n=5; second trimester: 40 ± 25 ng/ml, n=ll; third trimester: 98 ± 46 ng/ml, n=13. A correlation coefficient of 0.70 is found between the duration of pregnancy and the PAI-1 level.Preliminary data indicate that the PAI-1 antigen level is increased in several disease states, including myocardial infarction and deep vein thrombosis.Thus, this newly developed ELISA allows a direct measurement of the fast-acting inhibitor of plasminogen activator in plasma. Application of this assay to plasma of non-pregnant and pregnant women substantiates previous results obtained with the use of functional assays. In order to quantitate PAI-1 antigen circulating in plasma, blood should be collected under conditions that prevent platelet stimulation.

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "First trimester of pregnancy"

1

Xu, Lingxia, Donmei Yan, Bin Li, Liping Tang, Peng Sun, and Fei Wang. Efficacy and safety of Yunkang oral liquil combined with conventional therapy for threatened miscarriage of first-trimester pregnancy A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2021. http://dx.doi.org/10.37766/inplasy2021.4.0105.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Viswanathan, Meera, Jennifer Cook Middleton, Alison Stuebe, Nancy Berkman, Alison N. Goulding, Skyler McLaurin-Jiang, Andrea B. Dotson, et al. Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacologic Interventions. Agency for Healthcare Research and Quality (AHRQ), April 2021. http://dx.doi.org/10.23970/ahrqepccer236.

Full text

Abstract:

Background. Untreated maternal mental health disorders can have devastating sequelae for the mother and child. For women who are currently or planning to become pregnant or are breastfeeding, a critical question is whether the benefits of treating psychiatric illness with pharmacologic interventions outweigh the harms for mother and child. Methods. We conducted a systematic review to assess the benefits and harms of pharmacologic interventions compared with placebo, no treatment, or other pharmacologic interventions for pregnant and postpartum women with mental health disorders. We searched four databases and other sources for evidence available from inception through June 5, 2020 and surveilled the literature through March 2, 2021; dually screened the results; and analyzed eligible studies. We included studies of pregnant, postpartum, or reproductive-age women with a new or preexisting diagnosis of a mental health disorder treated with pharmacotherapy; we excluded psychotherapy. Eligible comparators included women with the disorder but no pharmacotherapy or women who discontinued the pharmacotherapy before pregnancy. Results. A total of 164 studies (168 articles) met eligibility criteria. Brexanolone for depression onset in the third trimester or in the postpartum period probably improves depressive symptoms at 30 days (least square mean difference in the Hamilton Rating Scale for Depression, -2.6; p=0.02; N=209) when compared with placebo. Sertraline for postpartum depression may improve response (calculated relative risk [RR], 2.24; 95% confidence interval [CI], 0.95 to 5.24; N=36), remission (calculated RR, 2.51; 95% CI, 0.94 to 6.70; N=36), and depressive symptoms (p-values ranging from 0.01 to 0.05) when compared with placebo. Discontinuing use of mood stabilizers during pregnancy may increase recurrence (adjusted hazard ratio [AHR], 2.2; 95% CI, 1.2 to 4.2; N=89) and reduce time to recurrence of mood disorders (2 vs. 28 weeks, AHR, 12.1; 95% CI, 1.6 to 91; N=26) for bipolar disorder when compared with continued use. Brexanolone for depression onset in the third trimester or in the postpartum period may increase the risk of sedation or somnolence, leading to dose interruption or reduction when compared with placebo (5% vs. 0%). More than 95 percent of studies reporting on harms were observational in design and unable to fully account for confounding. These studies suggested some associations between benzodiazepine exposure before conception and ectopic pregnancy; between specific antidepressants during pregnancy and adverse maternal outcomes such as postpartum hemorrhage, preeclampsia, and spontaneous abortion, and child outcomes such as respiratory issues, low Apgar scores, persistent pulmonary hypertension of the newborn, depression in children, and autism spectrum disorder; between quetiapine or olanzapine and gestational diabetes; and between benzodiazepine and neonatal intensive care admissions. Causality cannot be inferred from these studies. We found insufficient evidence on benefits and harms from comparative effectiveness studies, with one exception: one study suggested a higher risk of overall congenital anomalies (adjusted RR [ARR], 1.85; 95% CI, 1.23 to 2.78; N=2,608) and cardiac anomalies (ARR, 2.25; 95% CI, 1.17 to 4.34; N=2,608) for lithium compared with lamotrigine during first- trimester exposure. Conclusions. Few studies have been conducted in pregnant and postpartum women on the benefits of pharmacotherapy; many studies report on harms but are of low quality. The limited evidence available is consistent with some benefit, and some studies suggested increased adverse events. However, because these studies could not rule out underlying disease severity as the cause of the association, the causal link between the exposure and adverse events is unclear. Patients and clinicians need to make an informed, collaborative decision on treatment choices.

APA, Harvard, Vancouver, ISO, and other styles

3

Gerrard, Meg. Antecedents of Pregnancy and Pregnancy Attrition in First Term Women Marines. Fort Belvoir, VA: Defense Technical Information Center, November 1989. http://dx.doi.org/10.21236/ada216868.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Stabin, M. G., E. E. Watson, M. Cristy, J. C. Ryman, K. F. Eckerman, J. L. Davis, D. Marshall, and M. K. Gehlen. Mathematical models and specific absorbed fractions of photon energy in the nonpregnant adult female and at the end of each trimester of pregnancy. Office of Scientific and Technical Information (OSTI), May 1995. http://dx.doi.org/10.2172/91944.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Emergency Contraceptive Pills: South East Asia Regional Training Manual. Population Council, 2005. http://dx.doi.org/10.31899/rh16.1016.

Full text

Abstract:

This manual aims to equip Master Trainers with appropriate knowledge on emergency contraceptive pills that can be used by a woman to prevent an unwanted pregnancy within three days of unprotected intercourse or a contraceptive accident such as condom leakage. The manual discusses emergency contraceptive pills and the provision of related services. After a day’s training, Master Trainers will have the knowledge and skills necessary to train service providers and workers on emergency contraceptive pills. Clinicians and program managers who would like to provide services or information on emergency contraceptive pills would also benefit from the manual. The manual is divided into four sessions. The first session provides an overview of the demographic and reproductive health situation in South Asia and discusses the role of emergency contraception as a reproductive health intervention. The second session defines emergency contraception and discusses details of when and how emergency contraceptive pills should be taken. Service delivery guidelines are covered in the third session. The fourth session covers counseling on emergency contraceptive pills and frequently asked questions.

APA, Harvard, Vancouver, ISO, and other styles

6

Repositioning post partum care in Kenya. Population Council, 2005. http://dx.doi.org/10.31899/rh16.1013.

Full text

Abstract:

In Kenya, although 45 percent of maternal deaths occur within the first 24 hours after childbirth and 65 percent of maternal deaths occur during the first week postpartum, health-care providers continue to advise on a first check-up six weeks after childbirth. The early postpartum period is also critical to newborn survival, with 50–70 percent of life-threatening newborn illnesses occurring in the first week. Yet most strategies to reduce maternal and perinatal morbidity and mortality have focused on pregnancy and birth. In addition to the heavy workload of providers who do not assess the mother post-delivery when she may bring her infant for immunization, lack of knowledge, poverty, cultural beliefs and practices perpetuate the problem. The only register that exists for mothers post-delivery is for family planning, thus perpetuating the lack of emphasis on the early postpartum period with no standardized register to record care given. To address this gap in service delivery, the Population Council defined the minimal services a mother and baby should receive from a skilled attendant after birth. As stated in this brief, the development of a standardized postpartum register is one step toward advocating for providing early postpartum care among health-service providers.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!